Cargando…
Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1–Bad–Bak pathway in peritoneal carcinomatosis
Peritoneal carcinomatosis (PC) is the most common secondary cancerous disease, and more effective novel regimens are needed. In this study, we identified a novel combination treatment for PC, chemotherapeutic agent mitomycin C in combination with mTOR (mammalian target of rapamycin) inhibitor rapamy...
Autores principales: | Song, X, Dilly, A-K, Kim, S-Y, Choudry, H A, Lee, Y J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607229/ https://www.ncbi.nlm.nih.gov/pubmed/24901052 http://dx.doi.org/10.1038/cddis.2014.242 |
Ejemplares similares
-
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
por: Roh, Seung Jae, et al.
Publicado: (2020) -
Bak apoptotic function is not directly regulated by phosphorylation
por: Tran, V H, et al.
Publicado: (2013) -
Impact of Mitomycin-C-Induced Neutropenia after Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis
por: Lee, Suk Jun, et al.
Publicado: (2021) -
Peritoneal Tuberculosis Mimicking Peritoneal Carcinomatosis
por: Akce, Mehmet, et al.
Publicado: (2014) -
Peritoneal carcinomatosis mimicking a peritoneal tuberculosis
por: Jung, Eun Young, et al.
Publicado: (2015)